Abbott Laboratories Stock Fundamentals
| ABT Stock | USD 114.22 2.32 1.99% |
Abbott Laboratories fundamentals help investors to digest information that contributes to Abbott Laboratories' financial success or failures. It also enables traders to predict the movement of Abbott Stock. The fundamental analysis module provides a way to measure Abbott Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abbott Laboratories stock.
At this time, Abbott Laboratories' Depreciation And Amortization is comparatively stable compared to the past year. EBIT is likely to gain to about 7.7 B in 2024, whereas Total Revenue is likely to drop slightly above 22.2 B in 2024. Abbott | Select Account or Indicator |
Abbott Laboratories Company Current Valuation Analysis
Abbott Laboratories' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Abbott Laboratories Current Valuation | 211.12 B |
Most of Abbott Laboratories' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abbott Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Abbott Current Valuation Historical Pattern
Today, most investors in Abbott Laboratories Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Abbott Laboratories' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Abbott Laboratories current valuation as a starting point in their analysis.
Abbott Laboratories Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Abbott Laboratories has a Current Valuation of 211.12 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is significantly lower than that of the firm.
Abbott Laboratories Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Abbott Laboratories's current stock value. Our valuation model uses many indicators to compare Abbott Laboratories value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abbott Laboratories competition to find correlations between indicators driving Abbott Laboratories's intrinsic value. More Info.Abbott Laboratories is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers reporting about 0.43 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Abbott Laboratories is roughly 2.31 . At this time, Abbott Laboratories' Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Abbott Laboratories by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Abbott Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abbott Laboratories' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abbott Laboratories could also be used in its relative valuation, which is a method of valuing Abbott Laboratories by comparing valuation metrics of similar companies.Abbott Laboratories is currently under evaluation in current valuation category among its peers.
Abbott Laboratories ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Abbott Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Abbott Laboratories' managers, analysts, and investors.Environmental | Governance | Social |
Abbott Fundamentals
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0626 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 211.12 B | ||||
| Shares Outstanding | 1.74 B | ||||
| Shares Owned By Insiders | 0.52 % | ||||
| Shares Owned By Institutions | 79.63 % | ||||
| Number Of Shares Shorted | 11.83 M | ||||
| Price To Earning | 24.14 X | ||||
| Price To Book | 5.18 X | ||||
| Price To Sales | 4.94 X | ||||
| Revenue | 40.11 B | ||||
| Gross Profit | 24.58 B | ||||
| EBITDA | 10.59 B | ||||
| Net Income | 5.7 B | ||||
| Cash And Equivalents | 9.88 B | ||||
| Cash Per Share | 5.68 X | ||||
| Total Debt | 15.87 B | ||||
| Debt To Equity | 0.46 % | ||||
| Current Ratio | 1.86 X | ||||
| Book Value Per Share | 22.60 X | ||||
| Cash Flow From Operations | 7.26 B | ||||
| Short Ratio | 2.44 X | ||||
| Earnings Per Share | 3.27 X | ||||
| Price To Earnings To Growth | 2.27 X | ||||
| Target Price | 129.76 | ||||
| Number Of Employees | 114 K | ||||
| Beta | 0.72 | ||||
| Market Capitalization | 203.58 B | ||||
| Total Asset | 73.21 B | ||||
| Retained Earnings | 37.55 B | ||||
| Working Capital | 8.83 B | ||||
| Current Asset | 14.15 B | ||||
| Current Liabilities | 9.19 B | ||||
| Annual Yield | 0.02 % | ||||
| Five Year Return | 1.54 % | ||||
| Net Asset | 73.21 B | ||||
| Last Dividend Paid | 2.2 |
About Abbott Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Abbott Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbott Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbott Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 442.8 M | 420.7 M | |
| Total Revenue | 40.1 B | 22.2 B | |
| Cost Of Revenue | 18 B | 9.6 B | |
| Stock Based Compensation To Revenue | 0.02 | 0.01 | |
| Sales General And Administrative To Revenue | 0.29 | 0.22 | |
| Research And Ddevelopement To Revenue | 0.07 | 0.10 | |
| Capex To Revenue | 0.05 | 0.07 | |
| Revenue Per Share | 23.05 | 24.20 | |
| Ebit Per Revenue | 0.16 | 0.21 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.